Trevi Therapeutics TRVI 深 滬
等待開盤 09-18 09:30:00 美东时间
7.98
+0.020
+0.25%
華盛通- 最 高8.23
- 今 開8.00
- 成交量 118.39万股
- 最 低 7.97
- 昨 收 7.96
- 總市值 9.74亿
- 52周最高 9.92
- 市盈率 靜 --
- 換手率 0.97%
- 52周最低 2.36
- 委 比 7.92%
- 總股本 1.22亿
- 歷史最高 10.62
- 量 比 0.26
- 振 幅 3.27%
- 歷史最低 0.46
- 每 手 1
- 風險率 0.75%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Trevi Therapeutics to Participate in Upcoming September Conferences
NEW HAVEN, Conn., Aug. 28, 2025 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalb...
08-28 19:30
Trevi spikes as B. Riley reportedly cites deal prospects
Trevi Therapeutics (NASDAQ:TRVI), a clinical-stage biopharma focused on treatments for cough conditions, traded higher on Wednesday after B. Riley, with a Buy rating, reportedly highlighted the compan...
08-28 02:48
Trevi Therapeutics CFO Resignation Announced
Trevi Therapeutics ( ($TRVI) ) has issued an announcement. On August 14, 2025, ...
08-21 05:00
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
08-11 09:43
Needham Maintains Buy on Trevi Therapeutics, Lowers Price Target to $22
Needham analyst Serge Belanger maintains Trevi Therapeutics (NASDAQ:TRVI) with a Buy and lowers the price target from $24 to $22.
08-08 19:32
快讯 | Trevi Therapeutics Inc - 宣布Coral 2B期临床试验结果积极
Trevi Therapeutics Inc - Announces Positive Results From Phase 2B Coral Trial
08-08 04:31
快讯 | Trevi Therapeutics Inc - 请求与FDA进行二期结束会议
Trevi Therapeutics Inc - to Request End-of-Phase 2 Meeting With FDA
08-08 04:31
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Trevi Therapeutics to Participate in Upcoming August Conferences
NEW HAVEN, Conn., July 29, 2025 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalb...
07-29 19:30
